化学療法に伴う末梢神経障害:世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Chemotherapy Induced Peripheral Neuropathy 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chemotherapy Induced Peripheral Neuropathy to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chemotherapy Induced Peripheral Neuropathy to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Chemotherapy Induced Peripheral Neuropathy 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Chemotherapy Induced Peripheral Neuropathy Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Chemotherapy Induced Peripheral Neuropathy 33
Dec 23, 2011: EpiCept Receives FDA Permission To Initiate AmiKet Phase III Clinical Development 33
Jul 20, 2011: Lee’s Pharma Completes Last Patient Follow-Up In Clinical Study On Acetyl L-Carnitine Tablets For Treatment Of Peripheral Neuropathy 33
May 09, 2011: Lee’s Pharma Completes Patient Enrollment In Clinical Study On Acetyl L-Carnitine Tablets For Treatment Of Peripheral Neuropathy 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Sigma-Tau S.p.A. 35
Clinical Trial Overview of Sigma-Tau S.p.A. 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
NEMA Research Inc. 37
Clinical Trial Overview of NEMA Research Inc. 37
Mundipharma International Limited 38
Clinical Trial Overview of Mundipharma International Limited 38
Lee’s Pharmaceutical Holdings Limited 39
Clinical Trial Overview of Lee’s Pharmaceutical Holdings Limited 39
Johnson & Johnson 40
Clinical Trial Overview of Johnson & Johnson 40
EpiCept Corporation (Inactive) 41
Clinical Trial Overview of EpiCept Corporation (Inactive) 41
DARA BioSciences, Inc. 42
Clinical Trial Overview of DARA BioSciences, Inc. 42
CeNeRx BioPharma, Inc. 43
Clinical Trial Overview of CeNeRx BioPharma, Inc. 43
Ajanta Pharma Limited 44
Clinical Trial Overview of Ajanta Pharma Limited 44
Clinical Trial Overview of Top Institutes / Government 45
North Central Cancer Treatment Group 45
Clinical Trial Overview of North Central Cancer Treatment Group 45
Meiwa Hospital 46
Clinical Trial Overview of Meiwa Hospital 46
The University of Texas M. D. Anderson Cancer Center 47
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 47
Mayo Clinic 48
Clinical Trial Overview of Mayo Clinic 48
Columbia University 49
Clinical Trial Overview of Columbia University 49
Legacy Health System 50
Clinical Trial Overview of Legacy Health System 50
Northwestern University 51
Clinical Trial Overview of Northwestern University 51
The Cancer and Leukemia Group B 52
Clinical Trial Overview of The Cancer and Leukemia Group B 52
Gynecologic Oncology Group 53
Clinical Trial Overview of Gynecologic Oncology Group 53
Tata Memorial Hospital 54
Clinical Trial Overview of Tata Memorial Hospital 54
Five Key Clinical Profiles 55
Appendix 132
Abbreviations 132
Definitions 132
Research Methodology 133
Secondary Research 133
About GlobalData 134
Contact Us 134
Disclaimer 134
Source 135


【レポート販売概要】

■ タイトル:化学療法に伴う末梢神経障害:世界の臨床試験レビュー(2014年上半期)
■ 英文:Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014
■ 発行日:2014年3月19日
■ 調査会社:GlobalData
■ 商品コード:GDHC2033CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。